Senate Finance Committee Ranking Member Ron Wyden (D-OR), along with a group of Senate Democrats, released a 48-page Request for Information (RFI) outlining potential reforms to lower prescription drug costs, reduce patient out-of-pocket spending, and strengthen U.S. biopharmaceutical innovation (press release). The RFI builds on the drug pricing provisions enacted in the Inflation Reduction Act (IRA) and seeks stakeholder feedback… (Colocho, June 16, 2026) #Costs, #Demonstration Programs, #Drug Pricing, #Generic Drugs, #Medicare Part D, #Prescription Drugs